We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy
EP33057
Abstract: Researchers have found that DNA variations outside the exons can affect gene activity and protein production and lead to genetic disorders--variations that whole exome sequencing would miss. WGS, also known as complete genome sequencing, determines the order of all the nucleotides in an individual's DNA and can determine variations in any part of the genome at a single time. https://www.creative-biolabs.com/suprecision/whole-genome-sequencing-service-for-cancer.htmSummary: Whole genome sequencing (WGS) is a key driver for many medical research projects in cancer and complex genetic disorders. Creative Biolabs has established the high-throughput SuPrecision™ platform for large-scale sequencing services. Based on this advanced platform, we can provide the most comprehensive cancer WGS sequencing bioinformatics analysis for our global customers.
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Related Posters
Cancer Panels for Your Cancer Research
CD Genomics
A Gene Mutation Panel with Non-NGS Technologies
CD Genomics
Custom NGS Panel
CD Genomics
miRNA: Introduction, Profiling Methods, and Applications
CD Genomics
Insight Into Tumor Heterogeneity Through NGS
CD Genomics
